Sign in to our library of over $5 million worth of researchclose

Two Quick Steps

* Required Fields

Click Your Industry



Registered Customers

If you have an account with us, please log in.

* Required Fields



Subscribe today
Sign in to our library of over $5 million worth of researchclose

Two Quick Steps

* Required Fields

Click Your Industry



Registered Customers

If you have an account with us, please log in.

* Required Fields



Subscribe today

We deliver Mobile Wallet Market Research and SWOT Analysis from Alternative Energy to Pharmaceuticals and Healthcare Market Research Reports to Digital Media.

Skip to Main Content »

Search Site
Researchers Currently Online:2034

Genzyme Corporation - Strategic SWOT Analysis Review

Genzyme Corporation - Strategic SWOT Analysis Review

Double click on above image to view full picture

Zoom Out
Zoom In
Additional Information
Price $125.00
Meta Description Genzyme Corporation (Genzyme) is a biotechnology company, which is developing and applying technologies in the life sciences to encounter unmet deadly diseases. Its products and services are focused on rare genetic disorders, kidney diseases, orthopedics,
Publisher GlobalData
Date of Report Dec 3, 2013
Quick Overview
Summary

Genzyme Corporation (Genzyme) is a biotechnology company, which is developing and applying technologies in the life sciences to encounter unmet deadly diseases. Its products and services are focused on rare genetic disorders, kidney diseases, orthopedics, organ transplant, cancer, and immune disease. The company is also developing products on cardiovascular diseases, neurodegenerative diseases and other areas. It operates through two business units, namely, Rare Diseases division and Multiple Sclerosis division. Genzyme is a subsidiary of Sanofi and is headquartered in Massachusetts, the US.

Genzyme Corporation Key Recent Developments

Feb 13, 2013: Sanofi To Invest €44m In Genzyme's Campus In Waterford, Ireland To Increase Lantus Production CapacitiesnMay 03, 2012: Genzyme Announces Regulatory Approvals Of Expanded Waterford, Ireland Manufacturing Plant
Apr 19, 2012: Genzyme's Biologics Support Center Achieves LEED Gold Certification

GlobalData’s Genzyme Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.

Note: Some sections may be missing if data is unavailable for the company.

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Table of Contents
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Section 1 - About the Company 4
Genzyme Corporation - Key Facts 4
Genzyme Corporation - Key Employees 5
Genzyme Corporation - Key Employee Biographies 6
Genzyme Corporation - Major Products and Services 7
Genzyme Corporation - Pharmaceutical Pipeline Products Data 8
Genzyme Corporation, Pipeline Products by Therapy Area 8
Genzyme Corporation, Pipeline Products by Development Phase 9
Genzyme Corporation - History 12
Genzyme Corporation - Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Genzyme Corporation - Key Manufacturing Facilities 24
Joint Venture 24
Section 2 – Company Analysis 25
Genzyme Corporation - Business Description 25
Genzyme Corporation - Corporate Strategy 26
Genzyme Corporation - SWOT Analysis 27
SWOT Analysis - Overview 27
Genzyme Corporation - Strengths 27
Strength - Strong Research and Development Activities 27
Strength - Synergy through Sanofi 27
Strength - Global Reach 27
Genzyme Corporation - Weaknesses 28
Weakness - Patent Litigations 28
Weakness - Product Recall Incidents 28
Genzyme Corporation - Opportunities 28
Opportunity - New Market Approvals and Launches 28
Opportunity - Awards and Recognition 28
Opportunity - Emerging Markets 29
Genzyme Corporation - Threats 29
Threat - Highly Competitive Industry 29
Threat - Lengthy Drug Approval Process 29
Threat - Increased Pricing Control 29
Threat - Emergence of Biogenerics / Biosimilars 29
Genzyme Corporation - Key Competitors 30
Section 3 – Company’s Lifesciences Financial Deals and Alliances 31
Genzyme Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 31
Genzyme Corporation, Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013 32
Genzyme Corporation, Recent Deals Summary 33
Section 4 – Company’s Recent Developments 35
Genzyme Corporation, Recent Developments 35
Feb 13, 2013: Sanofi To Invest €44m In Genzyme's Campus In Waterford, Ireland To Increase Lantus Production Capacities 35
May 03, 2012: Genzyme Announces Regulatory Approvals Of Expanded Waterford, Ireland Manufacturing Plant 35
Apr 19, 2012: Genzyme's Biologics Support Center Achieves LEED Gold Certification 35
Section 5 – Appendix 37
Methodology 37
About GlobalData 37
Contact Us 37
Disclaimer 37

List of Tables
Genzyme Corporation, Key Facts 4
Genzyme Corporation, Key Employees 5
Genzyme Corporation, Key Employee Biographies 6
Genzyme Corporation, Major Products and Services 7
Genzyme Corporation, Number of Pipeline Products by Therapy Area 8
Genzyme Corporation, Number of Pipeline Products by Development Stage 9
Genzyme Corporation, Pipeline Products By Therapy Area and Development Phase 10
Genzyme Corporation, History 12
Genzyme Corporation, Other Locations 16
Genzyme Corporation, Subsidiaries 21
Genzyme Corporation, Key Manufacturing Facilities 24
Genzyme Corporation, Joint Venture 24
Genzyme Corporation, Key Competitors 30
Genzyme Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 31
Genzyme Corporation, Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013 32
Genzyme Corporation, Recent Deals Summary 33

List of Figures
Genzyme Corporation, Pipeline Products by Therapy Area 8
Genzyme Corporation, Pipeline Products by Development Phase 9
Genzyme Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 31
Genzyme Corporation, Pharmaceuticals & Healthcare, Deals by Type, 2007 to YTD 2013 32




...